Retinal Pigment Epithelium in Human Donor Eyes Contains Higher Levels of Bisretinoids Including A2E in Periphery than Macula.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 06 2022
Historique:
entrez: 7 6 2022
pubmed: 8 6 2022
medline: 10 6 2022
Statut: ppublish

Résumé

With age, human retinal pigment epithelium (RPE) accumulates bisretinoid fluorophores that may impact cellular function and contribute to age-related macular degeneration (AMD). Bisretinoids are comprised of a central pyridinium, dihydropyridinium, or cyclohexadiene ring. The pyridinium bisretinoid A2E has been extensively studied, and its quantity in the macula has been questioned. Age-changes and distributions of other bisretinoids are not well characterized. We measured levels of three bisretinoids and oxidized A2E in macula and periphery in human donor eyes of different ages. Eyes (N = 139 donors, 61 women and 78 men, aged 40-80 years) were dissected into 8 mm diameter macular and temporal periphery punches. Using liquid chromatography - electrospray ionization - mass spectrometry (LC-ESI-MS) and an authentic synthesized standard, we quantified A2E (ng). Using LC-ESI-MS and a 50-eye-extract of A2E, we semiquantified A2E and 3 other compounds (eye extract equivalent units [EEEUs): A2-glycerophosphoethanolamine (A2GPE), dihydropyridine phosphatidyl ethanolamine (A2DHPE), and monofuranA2E (MFA2E). A2E quantities in ng and EEEUs were highly correlated (r = 0.97, P < 0.001). From 262 eyes, 5 to 9-fold higher levels were observed in the peripheral retina than in the macula for all assayed compounds. A2E, A2DHPE, and MFA2E increased with age, whereas A2GPE remained unaffected. No significant right-left or male-female differences were detected. Significantly higher levels were observed in the periphery than in the macula for all assayed compounds signifying biologic differences between these regions. Levels of oxidized A2E parallel native A2E and not the distribution of retinal illuminance. Data will assist with the interpretion of clinical trial outcomes of agents targeting bisretinoid-related pathways.

Identifiants

pubmed: 35671050
pii: 2778888
doi: 10.1167/iovs.63.6.6
pmc: PMC9187938
doi:

Substances chimiques

Lipofuscin 0
Plant Extracts 0
Pyridinium Compounds 0
Retinoids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Subventions

Organisme : NEI NIH HHS
ID : R01 EY027948
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002243
Pays : United States

Références

J Opt Soc Am A. 1988 Jan;5(1):146-50
pubmed: 3351651
Physiology (Bethesda). 2010 Feb;25(1):8-15
pubmed: 20134024
Nature. 1993 Feb 25;361(6414):724-6
pubmed: 8441466
Invest Ophthalmol Vis Sci. 2014 Jul 17;55(8):4832-41
pubmed: 25034602
J Biol Chem. 2009 Jul 24;284(30):20155-66
pubmed: 19478335
Angew Chem Int Ed Engl. 2002 Mar 1;41(5):814-7
pubmed: 12491345
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14609-13
pubmed: 9843937
Prog Retin Eye Res. 2012 Mar;31(2):121-35
pubmed: 22209824
Invest Ophthalmol Vis Sci. 2013 Aug 21;54(8):5684-93
pubmed: 23860757
Invest Ophthalmol Vis Sci. 2011 Nov 25;52(12):9084-90
pubmed: 22039245
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 15;1073:10-18
pubmed: 29232606
Arch Biochem Biophys. 2009 Mar 15;483(2):175-81
pubmed: 18926795
Int J Mol Sci. 2022 Jan 15;23(2):
pubmed: 35055111
Exp Eye Res. 1988 Jul;47(1):71-86
pubmed: 3409988
Dokl Biochem Biophys. 2009 Mar-Apr;425:98-101
pubmed: 19496332
Photochem Photobiol. 2004 Feb;79(2):127-36
pubmed: 15068025
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16182-7
pubmed: 17060630
Invest Ophthalmol Vis Sci. 2012 Jun 08;53(7):3536-44
pubmed: 22570342
Vision Res. 2010 Mar 31;50(7):729-36
pubmed: 19800359
Invest Ophthalmol Vis Sci. 1984 Feb;25(2):195-200
pubmed: 6698741
J Lipid Res. 2018 Sep;59(9):1620-1629
pubmed: 29986955
J Lipid Res. 2014 Mar;55(3):504-15
pubmed: 24367044
Invest Ophthalmol Vis Sci. 2013 Dec 19;54(13):8325-6
pubmed: 24356235
Exp Eye Res. 2004 Apr;78(4):895-8
pubmed: 15037123
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):35
pubmed: 32433758
Arch Biochem Biophys. 2013 Nov 15;539(2):196-202
pubmed: 23969078
J Opt Soc Am. 1983 Nov;73(11):1544-50
pubmed: 6644400
Front Immunol. 2020 Nov 13;11:604205
pubmed: 33281830
Ophthalmic Surg Lasers Imaging Retina. 2018 Oct 15;49(10):S34-S42
pubmed: 30339266
Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):6904-9
pubmed: 27274068
Prog Retin Eye Res. 2021 Mar;81:100893
pubmed: 32758681
J Biomed Opt. 2018 Sep;23(9):1-20
pubmed: 30182580
J Comp Neurol. 1990 Feb 22;292(4):497-523
pubmed: 2324310
Exp Eye Res. 2014 Sep;126:61-7
pubmed: 25152361
Adv Exp Med Biol. 2019;1185:341-346
pubmed: 31884635
Anal Bioanal Chem. 2015 Feb;407(4):1075-88
pubmed: 25471291
Free Radic Biol Med. 1991;10(6):445-7
pubmed: 1894166
Photochem Photobiol Sci. 2015 Oct;14(10):1888-95
pubmed: 26223373
Invest Ophthalmol Vis Sci. 1978 Jul;17(7):601-7
pubmed: 669891
Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):269-277
pubmed: 32487917
Invest Ophthalmol Vis Sci. 2013 Aug 15;54(8):5535-42
pubmed: 23847313
Sci Rep. 2017 Dec 11;7(1):17352
pubmed: 29229934
Invest Ophthalmol Vis Sci. 2013 Aug 15;54(8):5543
pubmed: 23950159
Arch Gerontol Geriatr. 2002 May-Jun;34(3):169-84
pubmed: 14764321
J Chromatogr A. 2012 Aug 17;1251:232-235
pubmed: 22771064
J Biol Chem. 2005 Dec 2;280(48):39732-9
pubmed: 16186115
J Cell Mol Med. 2021 Jun;25(12):5572-5585
pubmed: 33934486
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7091-6
pubmed: 15870200
Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):13
pubmed: 32648890
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4164-9
pubmed: 15749821
Physiol Rev. 2005 Jul;85(3):845-81
pubmed: 15987797
Nutr Rev. 2003 Oct;61(10):342-6
pubmed: 14604266
Br J Ophthalmol. 2022 Mar;106(3):297-304
pubmed: 33741584
J Cell Sci Suppl. 1993;17:189-95
pubmed: 8144697
Science. 1969 Dec 19;166(3912):1535-6
pubmed: 17655054
Cell Mol Life Sci. 2020 Mar;77(5):789-805
pubmed: 31897543
J Biol Chem. 2013 Dec 13;288(50):35671-82
pubmed: 24169698
Photochem Photobiol Sci. 2015 Nov;14(11):1983-90
pubmed: 26323192
Eye (Lond). 1995;9 ( Pt 6):763-71
pubmed: 8849547
J Biol Chem. 2018 Dec 14;293(50):19400-19410
pubmed: 30352873

Auteurs

Ankita Kotnala (A)

Ocular Pharmacology & Pharmacy Division, All India Institute of Medical Sciences, New Delhi, India.

Srinivasan Senthilkumari (S)

Department of Ocular Pharmacology, Aravind Medical Research Foundation (AMRF), Dr. G. Venkataswamy Eye Research Institute, #1, Anna Nagar, Madurai -20, Tamilnadu, India.

Gong Wu (G)

Department of Biostatics, Vanderbilt University Medical Centre, Nashville, Tennessee, United States.

Thomas G Stewart (TG)

Department of Biostatics, Vanderbilt University Medical Centre, Nashville, Tennessee, United States.

Christine A Curcio (CA)

Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States.

Nabanita Halder (N)

Ocular Pharmacology & Pharmacy Division, All India Institute of Medical Sciences, New Delhi, India.

Sundararajan Baskar Singh (SB)

Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.

Atul Kumar (A)

Department of Ophthalmology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Thirumurthy Velpandian (T)

Ocular Pharmacology & Pharmacy Division, All India Institute of Medical Sciences, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH